{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:12:20Z","timestamp":1772575940394,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1053\/j.seminoncol.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T20:50:40Z","timestamp":1337028640000},"page":"253-262","source":"Crossref","is-referenced-by-count":9,"title":["Lymphoma Vaccine Therapy: Next Steps After a Positive, Controlled Phase III Clinical Trial"],"prefix":"10.1053","volume":"39","author":[{"given":"Sheeba K.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry W.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2012.02.014_bib1","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1073\/pnas.68.12.3130","article-title":"Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins","volume":"68","author":"Sirisinha","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib2","first-page":"2268","article-title":"Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target","volume":"36","author":"Stevenson","year":"1977","journal-title":"Fed Proc"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/254714a0","article-title":"Antibody to a molecularly-defined antigen confined to a tumour cell surface","volume":"254","author":"Stevenson","year":"1975","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4049\/jimmunol.121.2.479","article-title":"Participation of the humoral immune system in the myeloma-specific transplantation resistance","volume":"121","author":"Bridges","year":"1978","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib5","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4049\/jimmunol.120.5.1620","article-title":"Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy","volume":"120","author":"Daley","year":"1978","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4049\/jimmunol.138.2.628","article-title":"Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1","volume":"138","author":"George","year":"1987","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-3083.1980.tb00205.x","article-title":"Immunization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315","volume":"11","author":"Jorgensen","year":"1980","journal-title":"Scand J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4049\/jimmunol.138.4.1289","article-title":"Idiotype vaccination against murine B cell lymphoma","volume":"138","author":"Kaminski","year":"1987","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib9","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V76.11.2411.2411","article-title":"Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin","volume":"76","author":"Kwak","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib10","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.93.20.10972","article-title":"Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte\/macrophage colony-stimulating factor primes mice for a protective T-cell response","volume":"93","author":"Kwak","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4049\/jimmunol.130.2.970","article-title":"Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation","volume":"130","author":"Stevenson","year":"1983","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.140.6.1547","article-title":"Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice","volume":"140","author":"Sugai","year":"1974","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/13928","article-title":"Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma","volume":"5","author":"Bendandi","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","article-title":"Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors","volume":"327","author":"Kwak","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1073\/pnas.69.6.1540","article-title":"Myeloma proteins as tumor-specific transplantation antigens","volume":"69","author":"Lynch","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jnci\/56.4.735","article-title":"Tumor immunity induced by preimmunization with BALB\/c mouse myeloma protein","volume":"56","author":"Freedman","year":"1976","journal-title":"JNCI"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib17","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma\u2014long-term results of a clinical trial","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.blre.2008.09.001","article-title":"Vaccines for lymphomas: idiotype vaccines and beyond","volume":"23","author":"Houot","year":"2009","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib19","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1200\/JCO.2004.06.003","article-title":"Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype","volume":"22","author":"Weng","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20020338","article-title":"Inducing tumor immunity through the selective engagement of activating Fc gamma receptors on dendritic cells","volume":"195","author":"Kalergis","year":"2002","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V99.5.1517","article-title":"Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients","volume":"99","author":"Timmerman","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib22","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.0803636105","article-title":"Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study","volume":"105","author":"McCormick","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/djj358","article-title":"Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma","volume":"98","author":"Inoges","year":"2006","journal-title":"JNCI"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nm1290","article-title":"Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma","volume":"11","author":"Neelapu","year":"2005","journal-title":"Nature Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib25","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI20312","article-title":"Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes","volume":"113","author":"Baskar","year":"2004","journal-title":"J Clin Invest"},{"issue":"29","key":"10.1053\/j.seminoncol.2012.02.014_bib26","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2010.33.3005","article-title":"Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma","author":"Schuster","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib27","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2008.19.8903","article-title":"Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma","volume":"27","author":"Freedman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib28","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood.V83.11.3279.3279","article-title":"Idiotypic vaccination against human B-cell lymphoma","volume":"83","author":"Hawkins","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nm0996-1038","article-title":"DNA immunization induces protective immunity against B-cell lymphoma","volume":"2","author":"Syrengelas","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib30","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.167.11.6644","article-title":"Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens","volume":"167","author":"Biragyn","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.286.5439.525","article-title":"Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6","volume":"286","author":"Yang","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1075565","article-title":"Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2","volume":"298","author":"Biragyn","year":"2002","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/sonc.2003.50038","article-title":"Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Kyle","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.2008.17.7865","article-title":"Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/6995","article-title":"Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity","volume":"17","author":"Biragyn","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1053\/j.seminoncol.2012.02.014_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3816\/CLM.2006.n.013","article-title":"Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia","volume":"6","author":"Kimby","year":"2006","journal-title":"Clin Lymph Myeloma"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775412000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775412000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T18:57:56Z","timestamp":1687460276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775412000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0093775412000553"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2012.02.014","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}